The site will be unavailable in 50 minutes for scheduled maintenance.

$12.15 -0.90 (-6.90%)
2/10/2012 3:59 PM

Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)

CAPS Rating: 3 out of 5

A biopharmaceutical company developing novel therapeutics based on RNA interference, which is a naturally occurring biological pathway within cells for selectively silencing and regulating specific genes.

Featured Broker Partners


Advertisement